Literature DB >> 10998376

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.

S Günther1, P Emmerich, T Laue, O Kühle, M Asper, A Jung, T Grewing, J ter Meulen, H Schmitz.   

Abstract

We describe the isolation and characterization of a new Lassa virus strain imported into Germany by a traveler who had visited Ghana, Côte D'Ivoire, and Burkina Faso. This strain, designated "AV," originated from a region in West Africa where Lassa fever has not been reported. Viral S RNA isolated from the patient's serum was amplified and sequenced. A long-range reverse transcription polymerase chain reaction allowed amplification of the full-length (3.4 kb) S RNA. The coding sequences of strain AV differed from those of all known Lassa prototype strains (Josiah, Nigeria, and LP) by approximately 20%, mainly at third codon positions. Phylogenetically, strain AV appears to be most closely related to strain Josiah from Sierra Leone. Lassa viruses comprise a group of genetically highly diverse strains, which has implications for vaccine development. The new method for full-length S RNA amplification may facilitate identification and molecular analysis of new arenaviruses or arenavirus strains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998376      PMCID: PMC2627947          DOI: 10.3201/eid0605.000504

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  40 in total

1.  Lassa fever in the United States. Investigation of a case and new guidelines for management.

Authors:  G P Holmes; J B McCormick; S C Trock; R A Chase; S M Lewis; C A Mason; P A Hall; L S Brammer; G I Perez-Oronoz; M K McDonnell
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

2.  Imported Lassa fever--reexamining the algorithms.

Authors:  K M Johnson; T P Monath
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

3.  Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products.

Authors:  J C Clegg; S M Wilson; J D Oram
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

4.  Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.

Authors:  S L Ruo; S W Mitchell; M P Kiley; L F Roumillat; S P Fisher-Hoch; J B McCormick
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

5.  Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1.

Authors:  A G Krasko; A B Moshnikova; A T Kozhich; L D Tchikin; V T Ivanov; A S Vladyko; I S Lukashevich
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Lassa fever: the first confirmed case imported into Canada.

Authors:  M S Mahdy; W Chiang; B McLaughlin; K Derksen; B H Truxton; K Neg
Journal:  Can Dis Wkly Rep       Date:  1989-09-30

7.  Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies.

Authors:  F T Hufert; W Lüdke; H Schmitz
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Generation of reassortants between African arenaviruses.

Authors:  I S Lukashevich
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

Review 9.  Lassa fever: implications of T-cell immunity for vaccine development.

Authors:  J ter Meulen
Journal:  J Biotechnol       Date:  1999-08-20       Impact factor: 3.307

10.  Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region.

Authors:  S M Wilson; J C Clegg
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  84 in total

1.  Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein.

Authors:  O Lenz; J ter Meulen; H Feldmann; H D Klenk; W Garten
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.

Authors:  Delphine Pannetier; Stéphanie Reynard; Marion Russier; Alexandra Journeaux; Noël Tordo; Vincent Deubel; Sylvain Baize
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

Authors:  Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

4.  Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification.

Authors:  Aiko Fukuma; Yohei Kurosaki; Yuko Morikawa; Allen Grolla; Heinz Feldmann; Jiro Yasuda
Journal:  Microbiol Immunol       Date:  2011-01       Impact factor: 1.955

5.  Current molecular epidemiology of Lassa virus in Nigeria.

Authors:  Deborah U Ehichioya; Meike Hass; Beate Becker-Ziaja; Jacqueline Ehimuan; Danny A Asogun; Elisabeth Fichet-Calvet; Katja Kleinsteuber; Michaela Lelke; Jan ter Meulen; George O Akpede; Sunday A Omilabu; Stephan Günther; Stephan Olschläger
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

6.  Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.

Authors:  Markus Mordstein; Eva Neugebauer; Vanessa Ditt; Birthe Jessen; Toni Rieger; Valeria Falcone; Frederic Sorgeloos; Stephan Ehl; Daniel Mayer; Georg Kochs; Martin Schwemmle; Stephan Günther; Christian Drosten; Thomas Michiels; Peter Staeheli
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

7.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.

Authors:  Peter J Bredenbeek; Richard Molenkamp; Willy J M Spaan; Vincent Deubel; Phillippe Marianneau; Maria S Salvato; Dmitry Moshkoff; Juan Zapata; Ilia Tikhonov; Jean Patterson; Ricardo Carrion; Anysha Ticer; Kathleen Brasky; Igor S Lukashevich
Journal:  Virology       Date:  2006-01-18       Impact factor: 3.616

Review 9.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys.

Authors:  Sylvain Baize; Philippe Marianneau; Philippe Loth; Stéphanie Reynard; Alexandra Journeaux; Michèle Chevallier; Noël Tordo; Vincent Deubel; Hugues Contamin
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.